dr. axel grothey on the time course of regorafenib-associated adverse events
Published 11 years ago • 344 plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
2:03
dr. axel grothey on the side effect profile of regorafenib in metastatic colorectal cancer
-
3:54
colorectal cancer: patient follow-up with regorafenib
-
24:52
icaho 2017 - dr. axel grothey
-
0:57
dr. axel grothey examines the use of adjuvant oxaliplatin in colon cancer
-
1:35
dr. axel grothey on bevacizumab beyond progression in metastatic colorectal cancer
-
1:18
dr. grothey on treatment landscape of mcrc
-
1:27
dr. axel grothey on differences between correct and concur studies in mcrc
-
1:12
axel grothey, md, on the use of regorafenib in the management of advanced crc
-
10:18
obesity and risk of cancer
-
59:10
professor charlie gourley on rarer subtypes of ovarian cancer
-
1:09:38
gene & cell therapy als trial: transplanting stem cells into the motor cortex of patients with als
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
3:53
regorafenib in colorectal cancer: optimizing the dose
-
29:15
icaho20 - asco direct™ highlights - dr. axel grothey - colorectal cancer
-
1:20
dr. bekaii-saab on the use of regorafenib in patients with mcrc
-
11:50
colon cancer management - dr. axel grothey, part 1
-
8:35
dr. axel grothey on the best of esmo gi
-
1:49
dr. george demetri describes the mechanism of action of regorafenib in gist
-
7:35
use of regorafenib in refractory mcrc
-
9:34
regorafenib in colorectal cancer
-
8:47
colorectal cancer: dosing strategies with regorafenib
-
0:57
dr. grothey on biomarkers to inform metastatic crc treatment decisions